Thyrocare Tech surges 5% after Co authorises Dr. A Velumani to appoint CEO

The Board has also authorised Dr. A Velumani to identify a competent candidate for the position of Managing Director, CFO, and CIO.

Shares of Thyrocare Technologies surged over 5.5 per cent on the BSE on Friday, a day after the company informed that its board has authorised Dr. A Velumani, Chairman of the company, to identify and appoint a suitable candidate as a professional chief executive officer (CEO) for the company.

At 11:32 AM, the stock was trading over 4 per cent higher at Rs 798 on the BSE as compared to a 0.09 per cent fall in the S&P BSE Sensex at 38,807 levels. The stock had hit a high of Rs 809.80 in the early trade, up 5.6 per cent against